Loading…
Transaction to result in Aptorum Group holding 70% of combined entity.
Aptorum Group Limited and DiamiR Biosciences announced on July 16, 2025 Aptorum Group Limited and DiamiR Biosciences have entered into a definitive agreement for an all-stock merger transaction.
The announcement cited 70%, and 30%. Share consideration (payable in the issuer's shares): a number of shares of its common stock which will represent approximately 70% of the outstanding common stock of Aptorum Group.
Aptorum Group Limited Class A Ordinary Shares has a free float of 3,863,800 shares and 6,346,800 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.